Antiarrhythmic versus antifibrillatory actions: inference from experimental studies.

[1]  L. Hinkle,et al.  The immediate antecedents of sudden death. , 2009, Acta medica Scandinavica. Supplementum.

[2]  L. Chi,et al.  Antifibrillatory and Profibrillatory Actions of Selected Class I Antiarrhythmic Agents , 1993, Journal of cardiovascular pharmacology.

[3]  L. Chi,et al.  Actions of Pinacidil at a Reduced Potassium Concentration: A Direct Cardiac Effect Possibly Involving the ATP‐Dependent Potassium Channel , 1993, Journal of cardiovascular pharmacology.

[4]  G. Gross,et al.  Pharmacological Evidence for a Role of ATP‐Dependent Potassium Channels in Myocardial Stunning , 1992, Circulation.

[5]  J. Lynch,et al.  Effect of E‐4031, a Class III Antiarrhythmic Agent, on Experimental Infarct Size in a Canine Model of Myocardial Ischemia‐Reperfusion Injury , 1992, Journal of cardiovascular pharmacology.

[6]  J. M. Di Diego,et al.  Role of K+ channel activators in cardiac electrophysiology and arrhythmias. , 1992, Circulation.

[7]  A. Buxton.  Antiarrhythmic Drugs: Good for Premature Ventricular Complexes but Bad for Patients? , 1992, Annals of Internal Medicine.

[8]  G. Gross,et al.  Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. , 1992, Circulation research.

[9]  G. Gross,et al.  The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. , 1991, The Journal of pharmacology and experimental therapeutics.

[10]  W. Lederer,et al.  Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. , 1991, The American journal of physiology.

[11]  H. Selnick,et al.  Cardiac Electrophysiologic and Inotropic Actions of New and Potent Methanesulfonanilide Class III Antiarrhythmic Agents in Anesthetized Dogs , 1991, Journal of cardiovascular pharmacology.

[12]  A. Uprichard,et al.  Hypothyroidism Renders Protection Against Lethal Ventricular Arrhythmias in a Conscious Canine Model of Sudden Death , 1991, Journal of cardiovascular pharmacology.

[13]  W. Lederer,et al.  ATP dependence of KATP channel kinetics in isolated membrane patches from rat ventricle. , 1991, Biophysical journal.

[14]  Lippincott Williams Wilkins,et al.  The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. , 1991, Circulation.

[15]  J. Weiss,et al.  Sulfonylureas, ATP-sensitive K+ channels, and cellular K+ loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle. , 1991, Circulation research.

[16]  L. Chi,et al.  The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent. , 1991, The Journal of pharmacology and experimental therapeutics.

[17]  P. Poole‐Wilson,et al.  Inhibition by barium and glibenclamide of the net loss of 86Rb+ from rabbit myocardium during hypoxia. , 1991, Cardiovascular research.

[18]  S M Cobbe,et al.  Effect of glibenclamide on extracellular potassium accumulation and the electrophysiological changes during myocardial ischaemia in the arterially perfused interventricular septum of rabbit. , 1991, Cardiovascular research.

[19]  L. Chi,et al.  Electrophysiology and Antiarrhythmic Actions of E‐4031 in the Experimental Animal Model of Sudden Coronary Death , 1991, Journal of cardiovascular pharmacology.

[20]  R. Vaughan-Jones,et al.  Mechanism of potassium efflux and action potential shortening during ischaemia in isolated mammalian cardiac muscle. , 1990, The Journal of physiology.

[21]  G. Grover,et al.  Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891. , 1990, European journal of pharmacology.

[22]  Z. Fan,et al.  Multiple actions of pinacidil on adenosine triphosphate‐sensitive potassium channels in guinea‐pig ventricular myocytes. , 1990, The Journal of physiology.

[23]  L. Chi,et al.  Antiarrhythmic and Electrophysiologic Actions of CK‐357 and Sematilide in a Conscious Canine Model of Sudden Coronary Death , 1990, Journal of cardiovascular pharmacology.

[24]  L. Chi,et al.  Effects of Combined Thromboxane Synthetase Inhibition/Thromboxane Receptor Antagonism in Two Models of Sudden Cardiac Death in the Canine: Limited Role for Thromboxane , 1990, Journal of cardiovascular pharmacology.

[25]  D. Robertson,et al.  Potassium channel modulators: scientific applications and therapeutic promise. , 1990, Journal of medicinal chemistry.

[26]  M. Allessie,et al.  Double-wave reentry as a mechanism of acceleration of ventricular tachycardia. , 1990, Circulation.

[27]  W. Lederer,et al.  The regulation of ATP‐sensitive K+ channel activity in intact and permeabilized rat ventricular myocytes. , 1990, The Journal of physiology.

[28]  L. Chi,et al.  Profibrillatory Actions of Pinacidil in a Conscious Canine Model of Sudden Coronary Death , 1990, Journal of cardiovascular pharmacology.

[29]  L. Opie,et al.  Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea. , 1990, Circulation research.

[30]  R. Kass,et al.  Activation of ATP-sensitive K channels in heart cells by pinacidil: dependence on ATP. , 1989, The American journal of physiology.

[31]  L. Chi,et al.  Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity. , 1989, The Journal of pharmacology and experimental therapeutics.

[32]  G. Grover,et al.  Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. , 1989, The Journal of pharmacology and experimental therapeutics.

[33]  J. Rozanski,et al.  Efficacy of procainamide on ventricular tachycardia: relation to prolongation of refractoriness and slowing of conduction. , 1989, American heart journal.

[34]  T. Colatsky,et al.  K+ Channel Blockers and Activators in Cardiac Arrhythmias , 1989 .

[35]  L. Chi,et al.  Alinidine Reduces the Incidence of Ischemic Ventricular Fibrillation in a Conscious Canine Model, a Protective Effect Antagonized by Overdrive Atrial Pacing , 1989, Journal of cardiovascular pharmacology.

[36]  M. Sanguinetti,et al.  Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts. , 1989, Journal of molecular and cellular cardiology.

[37]  D. Clapham,et al.  Potassium channels in cardiac cells activated by arachidonic acid and phospholipids. , 1989, Science.

[38]  Jeffrey L. Anderson,et al.  The ESVEM Trial: Electrophysiologic Study Versus Electrocardiographic Monitoring for Selection of Antiarrhythmic Therapy of Ventricular Tachyarrhythmias , 1989, Circulation.

[39]  L. Opie,et al.  Reduction in ischemic myocardial K+ efflux and arrhythmias by glibenclamide , 1988 .

[40]  J. K. Smallwood,et al.  Cardiac Electrophysiological Effects of Pinacidil and Related Pyridylcyanoguanidines: Relationship to Antihypertensive Activity , 1988, Journal of cardiovascular pharmacology.

[41]  M. Lazdunski,et al.  Antidiabetic sulfonylureas control action potential properties in heart cells via high affinity receptors that are linked to ATP-dependent K+ channels. , 1988, The Journal of biological chemistry.

[42]  J. Ruskin,et al.  Spontaneous and electrically induced ventricular arrhythmias during acute ischemia superimposed on 2 week old canine myocardial infarction. , 1988, Journal of the American College of Cardiology.

[43]  J. Kjekshus.  Heart rate reduction--a mechanism of benefit? , 1987, European heart journal.

[44]  B. Lucchesi,et al.  α-Adrenergic Influences in Canine Ischemic Sudden Death , 1987 .

[45]  G. Gross,et al.  Effect of the new specific bradycardia agent AQ-A39 (falipamil) on coronary collateral blood flow in dogs. , 1987, Journal of cardiovascular pharmacology.

[46]  B. Lucchesi,et al.  Antifibrillatory efficacy of concomitant beta adrenergic receptor blockade with dilevalol, the R,R-isomer of labetalol, and muscarinic receptor blockade with methylscopolamine. , 1987, The Journal of pharmacology and experimental therapeutics.

[47]  宏暢 高橋,et al.  Sodium 5-hydroxydecanoateの実験的虚血性心室性不整脈への効果とその作用機序に関する検討 , 1987 .

[48]  W. Kou,et al.  Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden death. , 1987, Journal of the American College of Cardiology.

[49]  Y. Vedernikov.  Mechanisms of coronary spasm of isolated human epicardial coronary segments excised 3 to 5 hours after sudden death. , 1986, Journal of the American College of Cardiology.

[50]  Lucchesi Br,et al.  Preclinical assessment of antiarrhythmic drugs. , 1986 .

[51]  W. Roberts.  Sudden cardiac death: definitions and causes. , 1986, The American journal of cardiology.

[52]  P. Kühn,et al.  [Celiprolol in acute myocardial infarct]. , 1986, Wiener klinische Wochenschrift.

[53]  J. Hammon,et al.  Interaction of platelets with the vessel wall in the pathophysiology of sudden cardiac death. , 1986, Circulation.

[54]  S. Factor,et al.  Smooth muscle contraction bands in the media of coronary arteries: a postmortem marker of antemortem coronary spasm? , 1985, Journal of the American College of Cardiology.

[55]  H. Saner,et al.  The disease-free wall in coronary atherosclerosis: its relation to degree of obstruction. , 1985, Journal of the American College of Cardiology.

[56]  B. Waller,et al.  Coronary luminal shape and the arc of disease-free wall: morphologic observations and clinical relevance. , 1985, Journal of the American College of Cardiology.

[57]  B. Lucchesi,et al.  Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models. , 1985, European journal of pharmacology.

[58]  B. Lucchesi,et al.  Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs. , 1985, The Journal of pharmacology and experimental therapeutics.

[59]  M. K. Heng,et al.  Reduction of ventricular arrhythmias by atenolol. , 1985, American heart journal.

[60]  R. Gordon,et al.  Celiprolol--pharmacological profile of an unconventional beta-blocker. , 1985, British journal of clinical practice. Supplement.

[61]  B. Lucchesi,et al.  Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death. , 1985, American heart journal.

[62]  Mazur Na.  [Sudden coronary death]. , 1985, Kardiologiia.

[63]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[64]  L. D. Davis,et al.  Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers. , 1985, Journal of the American College of Cardiology.

[65]  D. Cook,et al.  Intracellular ATP directly blocks K+ channels in pancreatic B-cells , 1984, Nature.

[66]  J. Mason,et al.  Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. , 1984, Circulation research.

[67]  J. Brachmann,et al.  Mechanisms of ventricular arrhythmias in multivessel coronary disease: the effects of collateral zone ischemia. , 1984, American heart journal.

[68]  B. Lucchesi,et al.  Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol. , 1984, The Journal of pharmacology and experimental therapeutics.

[69]  A. Jaffe,et al.  Risk factors for sudden death after acute myocardial infarction: two-year follow-up. , 1984, The American journal of cardiology.

[70]  J. M. Zimmerman,et al.  Antidysrhythmic actions of meobentine sulfate. , 1984, American heart journal.

[71]  M J Davies,et al.  Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. , 1984, The New England journal of medicine.

[72]  B. Lucchesi,et al.  Development of Ventricular Tachyarrhythmias in the Conscious Canine During the Recovery Phase of Experimental Ischemic Injury: Effect of Bethanidine Administration , 1984, Journal of cardiovascular pharmacology.

[73]  H. L. Stone,et al.  Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. , 1984, Circulation.

[74]  D. Warltier,et al.  Effects of three bradycardiac drugs on regional myocardial blood flow and function in areas distal to a total or partial coronary occlusion in dogs. , 1984, Circulation.

[75]  J P Miller,et al.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. , 1984, Circulation.

[76]  J. Bigger,et al.  Effects of timolol and propranolol on inducible sustained ventricular tachyarrhythmias in dogs with subacute myocardial infarction. , 1984, The American journal of cardiology.

[77]  J. Mason,et al.  Nature of inducible ventricular tachyarrhythmias in a canine chronic myocardial infarction model. , 1983, The American journal of cardiology.

[78]  W. Kobinger,et al.  Actions of Alinidine and AQ‐A 39 on Rate and Contractility of Guinea Pig Atria During β-Adrenoceptor Stimulation , 1983, Journal of cardiovascular pharmacology.

[79]  M. Josephson,et al.  Clinical characteristics and long-term follow-up in 119 survivors of cardiac arrest: relation to inducibility at electrophysiologic testing. , 1983, The American journal of cardiology.

[80]  B. Lucchesi,et al.  Ventricular fibrillation in a conscious canine preparation of sudden coronary death--prevention by short- and long-term amiodarone administration. , 1983, Circulation.

[81]  C. Furberg.  Effect of antiarrhythmic drugs on mortality after myocardial infarction. , 1983, The American journal of cardiology.

[82]  A. Noma,et al.  ATP-regulated K+ channels in cardiac muscle , 1983, Nature.

[83]  B. Lucchesi,et al.  Antifibrillatory Actions of d, l‐Nadolol in a Conscious Canine Model of Sudden Coronary Death , 1983, Journal of cardiovascular pharmacology.

[84]  J. Fleiss,et al.  Risk stratification and survival after myocardial infarction. , 1983, The New England journal of medicine.

[85]  G. Specchia,et al.  Ventricular tachyarrhythmias in Prinzmetal's variant angina: clinical significance and relation to the degree and time course of S-T segment elevation. , 1983, The American journal of cardiology.

[86]  B. Lucchesi,et al.  Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death. , 1983, American heart journal.

[87]  T. N. James,et al.  Acute effects of amiodarone upon the canine sinus node and atrioventricular junctional region. , 1983, The Journal of clinical investigation.

[88]  B. Lucchesi,et al.  Effects of diltiazem upon experimental ventricular dysrhythmias. , 1983, The Journal of pharmacology and experimental therapeutics.

[89]  B. Lucchesi,et al.  Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction. A conscious canine model of sudden coronary death. , 1982, The American journal of cardiology.

[90]  D. Waters,et al.  Clinical Characteristics Associated with Sudden Death in Patients with Variant Angina , 1982, Circulation.

[91]  A. Castellanos,et al.  Electrophysiologic consequences of experimental acute ischemia superimposed on healed myocardial infarction in cats. , 1982, The American journal of cardiology.

[92]  J. K. Gibson,et al.  Prevention of Chronic Canine Ventricular Tachyarrhythmias with Bretylium Tosylate , 1981, Circulation.

[93]  S. Goldstein,et al.  Characteristics of the Resuscitated Out‐of‐hospital Cardiac Arrest Victim with Coronary Heart Disease , 1981, Circulation.

[94]  J. Mehta,et al.  Role of blood platelets and prostaglandins in coronary artery disease. , 1981, The American journal of cardiology.

[95]  J. Millar,et al.  Pacemaker selectivity: influence on rabbit atria of ionic environment and of alinidine, a possible anion antagonist. , 1981, Cardiovascular research.

[96]  P. Corr,et al.  Increased alpha-adrenergic receptors in ischemic cat myocardium. A potential mediator of electrophysiological derangements. , 1981, The Journal of clinical investigation.

[97]  J. K. Gibson,et al.  Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate. , 1981, The Journal of pharmacology and experimental therapeutics.

[98]  H. L. Stone,et al.  Left Stellectomy in the Prevention of Ventricular Fibrillation Caused by Acute Myocardial Ischemia in Conscious Dogs with Anterior Myocardial Infarction , 1980, Circulation.

[99]  A Malliani,et al.  Neural mechanisms in life-threatening arrhythmias. , 1980, American heart journal.

[100]  B. Pitt,et al.  Kinetics of antifibrillatory effects of bretylium: correlation with myocardial drug concentrations. , 1980, The American journal of cardiology.

[101]  B. Bulkley,et al.  Ischemia at a Distance After Acute Myocardial Infarction: A Cause of Early Postinfarction Angina , 1980, Circulation.

[102]  H T Davis,et al.  Ventricular Ectopic Beats and Their Relation to Sudden and Nonsudden Cardiac Death After Myocardial Infarction , 1979, Circulation.

[103]  L. Pichler,et al.  Cardiovascular actions of N-allyl-clonidine (ST 567), a substance with specific bradycardic action. , 1979, European journal of pharmacology.

[104]  H. Karagueuzian,et al.  Protracted Ventricular Tachycardia Induced by Premature Stimulation of the Canine Heart after Coronary Artery Occlusion and Reperfusion , 1979 .

[105]  H. Karagueuzian,et al.  Protracted ventricular tachcardia induced by premature stimulation of the canine heart after coronary artery occlusion and reperfusion. , 1979, Circulation research.

[106]  S. Chierchia,et al.  "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. , 1978, The American journal of cardiology.

[107]  N. El-Sherif.  Reentrant Ventricular Arrhythmias in the Late Myocardial Infarction Period 6. Effect of the Autonomic System , 1978, Circulation.

[108]  R Lazzara,et al.  Re‐entrant Ventricular Arrhythmias in the Late Myocardial Infarction Period: 1. Conduction Characteristics in the Infarction Zone , 1977, Circulation.

[109]  W. Weaver,et al.  Angiographic Findings and Prognostic Indicators in Patients Resuscitated from Sudden Cardiac Death , 1976 .

[110]  W. Weaver,et al.  Angiographic findigs and prognostic indicators in patients resuscitated from sudden cardiac death. , 1976, Circulation.

[111]  F. Copp,et al.  Effects of bretylium on rat cardiac muscle: the electrophysiological effects and its uptake and binding in normal and immunosympathectomized rat hearts. , 1975, The Journal of pharmacology and experimental therapeutics.

[112]  H. Wellens,et al.  Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients. , 1974, The New England journal of medicine.

[113]  L. Cobb,et al.  Survival after Resuscitation from Out‐of‐Hospital Ventricular Fibrillation , 1974, Circulation.

[114]  R. Lazzara,et al.  The Efficacy of Antiarrhythmic Agents During Acute Myocardial Ischemia and the Role of Heart Rate , 1974, Circulation.

[115]  Jørgen W. Herem.  Mural platelet microthrombi and major acute lesions of main epicardial arteries in sudden coronary death. , 1974 .

[116]  J. Marshall,et al.  Action of thyroid hormone on the transmembrane potentials from sinoatrial node cells and atrial muscle cells in isolated atria of rabbits. , 1973, Cardiology.

[117]  A Malliani,et al.  A Cardiocardiac Sympathovagal Reflex in the Cat , 1973, Circulation research.

[118]  H. Wellens,et al.  Electrical Stimulation of the Heart in Patients with Ventricular Tachycardia , 1972, Circulation.

[119]  L. Kuller,et al.  Epidemiology of sudden death. , 1972, Archives of internal medicine.

[120]  R. Charlier.  Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors , 1970, British journal of pharmacology.

[121]  B. Singh,et al.  The effect of amiodarone, a new anti‐anginal drug, on cardiac muscle , 1970, British journal of pharmacology.

[122]  J. Papp,et al.  The effect of altered thyroid state on atrial intracellular potentials , 1970, The Journal of physiology.

[123]  D C Harrison,et al.  Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. , 1967, The New England journal of medicine.

[124]  W. Belton.  Consultants' views of general practitioners , 1967 .

[125]  H. Maling,et al.  Ventricular Arrhythmias Induced by Sympathomimetic Amines in Unanesthetized Dogs Following Coronary Artery Occlusion , 1957, Circulation research.

[126]  A. Castellanos,et al.  Sudden cardiac death. Structure, function, and time-dependence of risk. , 1992, Circulation.

[127]  J. Ruskin.  Role of invasive electrophysiological testing in the evaluation and treatment of patients at high risk for sudden cardiac death. , 1992, Circulation.

[128]  Robert Lemery,et al.  Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. , 1992, The New England journal of medicine.

[129]  P. Schwartz,et al.  Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. , 1992, Circulation.

[130]  W. Lederer,et al.  ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction. , 1991, Circulation research.

[131]  Michael R. Rosen,et al.  The 'Sicilian Gambit' - A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms , 1991 .

[132]  W. Rogers,et al.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.

[133]  A. Uprichard,et al.  Failure of thromboxane synthetase inhibition to protect the postinfarcted heart against the induction of ventricular tachycardia and ventricular fibrillation in a conscious canine model of sudden coronary death. , 1988, Pharmacology.

[134]  N. S. Cook,et al.  The pharmacology of potassium channels and their therapeutic potential. , 1988, Trends in pharmacological sciences.

[135]  F. Ashcroft.  Adenosine 5'-triphosphate-sensitive potassium channels. , 1988, Annual review of neuroscience.

[136]  T. Notsu,et al.  [Study of mechanism and effect of sodium 5-hydroxydecanoate on experimental ischemic ventricular arrhythmia]. , 1987, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[137]  L. DiCarlo,et al.  Effects of flecainide acetate on ventricular tachyarrhythmia and fibrillation in dogs with recent myocardial infarction. , 1987, Pharmacology.

[138]  B. Lucchesi,et al.  Preclinical assessment of antiarrhythmic drugs. , 1986, Federation proceedings.

[139]  E. Prystowsky,et al.  Survivors of cardiac arrest: prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring. , 1986, The American journal of cardiology.

[140]  Johan Herlitz,et al.  Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group. , 1985, European heart journal.

[141]  V. Em.  Cardiac Electrophysiological Effects of Selective Adrenoceptor Stimulation and Their Possible Roles in Arrhythmias , 1985, Journal of cardiovascular pharmacology.

[142]  B. Lucchesi,et al.  Postinfarction sudden death: significance of inducible ventricular tachycardia and infarct size in a conscious canine model. , 1985, American heart journal.

[143]  José Jalife,et al.  Cardiac electrophysiology and arrhythmias , 1985 .

[144]  B. Lucchesi,et al.  Clinical pharmacology of antiarrhythmic therapy , 1984 .

[145]  C. Furberg,et al.  Secondary prevention after myocardial infarction: a review of short-term acute phase trials. , 1983, Progress in cardiovascular diseases.

[146]  A. Camm,et al.  Drugs with a class III antiarrhythmic action. , 1982, Pharmacology & therapeutics.

[147]  A. Moss,et al.  Factors Associated with Cardiac Death in the Posthospital Phase of Myocardial Infarction , 1980 .

[148]  Anderson Hj,et al.  Recurrent Sustained Ventricular Tachycardia 1.Mechanisms , 1977 .

[149]  D. Reichenbach,et al.  Pathology of the heart in sudden cardiac death. , 1977, The American journal of cardiology.

[150]  E.M.Vaughan Williams D.M. D.Sc..  Classification of antidysrhythmic drugs. , 1975 .

[151]  J. Dudel,et al.  [The action current of the myocardial fibers in oxygen deficiency]. , 1954, Pflugers Archiv fur die gesamte Physiologie des Menschen und der Tiere.